Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is anti-TNF therapy safe in patients with rheumatic disease who also have concurrent B or C chronic hepatitis?

Nature Clinical Practice Rheumatology volume 3, pages 130–131 (2007)Cite this article

boxed-textRoux CH et al. (2006) Safety of anti-TNF-α therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis. Rheumatology (Oxford) 45: 1294–1297

Prophylactic antiviral therapy should be initiated along with immunosuppressive therapy and continued for 6 months after completion of treatment to prevent hepatitis B reactivation

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Perrillo RP (2001) Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease [see comment]. Gastroenterology 20: 1009–1022

    Article  Google Scholar 

  2. Liang RH et al. (1990) Hepatitis B infection in patients with lymphomas. Hematol Oncol 8: 261–270

    Article  CAS  Google Scholar 

  3. Yeo W et al. (2004) Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients. Breast Cancer Res Treat 88: 209–215

    Article  CAS  Google Scholar 

  4. Lok AS et al. (2001) Chronic hepatitis B [see comment]. Hepatology 34: 1225–1241

    Article  CAS  Google Scholar 

  5. Michel M et al. (2003) Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease. J Rheumatol 30: 1624–1625

    PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. University of Texas, Southwestern Medical Center, Department of Internal Medicine, Division of Digestive and Liver Diseases, 5323 Harry Hines Boulevard, F5.300, Dallas, Texas 75390-9030, USA dwain.thiele@utsouthwestern.edu

Authors and Affiliations

  1. DL Thiele is a Professor in the Department of Internal Medicine, Digestive and Liver diseases, at the Graduate School of Biomedical Sciences at Southwestern Medical School, Dallas, TX, USA.,

    Dwain L Thiele

Authors
  1. Dwain L Thiele
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thiele, D. Is anti-TNF therapy safe in patients with rheumatic disease who also have concurrent B or C chronic hepatitis?. Nat Rev Rheumatol 3, 130–131 (2007). https://doi.org/10.1038/ncprheum0403

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0403

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing